Draft mandate Morbidity and Mortality Working Party
|
|
- Carmel Nelson
- 6 years ago
- Views:
Transcription
1 Draft mandate Morbidity and Mortality Working Party Luxembourg, Purpose of the Morbidity and Mortality Working Party (MMWP) The purpose of the Morbidity and Mortality Working Party (MMWP) is to provide a forum for discussion and exchange of views and experience on information and knowledge in the fields of Morbidity and Mortality at National, Sub-national and European Union level. The MMWP will serve as an expert group to advise on information and knowledge for monitoring Community policies and other initiatives in the field of morbidity and mortality. The MMWP will act according to the terms of Decision No 1786/2002/EC of the European Parliament and of the Council of 23 September 2002 adopting a program of Community action in the field of public health ( ). This programme establishes in Article 3 (ii): activities to counter health threats, including major diseases, and react to unforeseen events, enable investigations and coordinate response; in Article 3 (iii): preparation, establishment and operation of appropriate structural arrangements coordinating and integrating networks for health monitoring and for rapid reaction to health threats, and in the Annex: developing strategies and mechanisms for preventing, exchanging information on and responding to noncommunicable disease threats, including gender-specific health threats and rare diseases. The concept of health information and knowledge should be understood for the major diseases as the collection, processing, sharing and analysis of objective, reliable, compatible and comparable data on diseases affecting human health. Issues to be addressed, to make disease information more relevant to Community action in the field of public health, include identification of the main user groups, of the problems identified at EU level - such as the quality of available data (e.g. timeliness, comparability), gaps in information and inaccessible data (e.g. data that are not widely available). The MMWP will thus contribute to the improvement of the information and knowledge for the development of public health. It will assist the Commission in the development and coordination of the Health Information System, completing the technical and scientific background work for the establishment of major and rare disease indicators and other information needs. 2. What dimensions of morbidity/mortality are we dealing with? The activity in the field of morbidity and mortality will concern non communicable diseases (including rare diseases) as well as chronic conditions in the following dimensions: Objective morbidity reflects real health needs independent from the subjective point of view of both the patient and the examiner. This is the classic incidence and prevalence data concerning the real health problems (diseases) as they are described by medical science at that time.
2 Self-reported morbidity is completely linked to the patient s personal feelings via HIS (Health Interview Surveys) independently from any objectivity or diagnosis. Risk factors for morbidity via national population based HES (Health Examination Surveys) with a general broad (non-disease specific/focused) health focus or as defined in some epidemiological studies. Other individual examinations performed of either in an entire survey or according to chosen health topics in some surveys. Diagnosed morbidity which only intervenes at the final stages of the process reflects both the results of the previous steps (hence the need and the demand), as well as the functioning of the health system itself. For this very reason, it is also an indicator of the socioeconomic implication of morbidity. Health conditions dimensions related to specific categories (e.g. child health, etc.) as well as indicators related to the International Classification of Functioning, Disability and Health (ICF). In this domain physical functioning is an aspect that could be analysed by the MMWP. Mortality, as the analysis of European mortality trends outlining the important differences for various causes of death before attempting to interpret the inter-country differences in terms of etiological factors assessing the possible biases affecting the comparability of the data. For the following diseases the MMWP will not deal with the morbidity dimension (but it will deal with the mortality dimension or with the morbid conditions leading to a disability): Communicable diseases, as defined by the Decision No EC/2119/1998 from the European Parliament and the Council, for which a Communicable Disease Surveillance and Control Network Committee has been created; Mental diseases, for which DG SANCO has created a specific Mental Health Working Party; Occupational diseases, for which an Ad hoc group from the Advisory Committee on Safety, Hygiene and Health at Work is responsible for the definition of the list. 3. Duration and members of the MMWP The MMWP is established for the duration of the Public Health Programme Participants in the Working Party are: Project leaders on morbidity and mortality projects under the Public health Programme and former Project leaders from the previous public health programmes in fields as: non communicable diseases, rare diseases, health surveys and causes of death;
3 When relevant competent national experts in morbidity and mortality as nominated by the Network of Competent Authorities among national institutions with expertise in these fields; In order to ensure a wide geographical representation as well as other necessary expertise, competent national experts in the corresponding fields could be invited by DG SANCO. Other participants in the Working Party could be: Project leaders from projects in the corresponding fields under other EU Programmes (BIOMED, Community Statistical Programme, etc.); Representatives from other concerned EC Directorate General s (Eurostat, RTD, ENTR, etc.) Representatives from other concerned international organisations, such as WHO or OECD; When relevant representatives from concerned private international organisations or international NGO s. Priority will be given to promote synergy and avoid duplication with the Community Statistical Programme. The statistical element of the system is developed via the Statistical Programme of the Commission for the year 2003 (adopted on October 2002) which in the Theme 35: Health and safety includes under the title New work the preparation of a collection of morbidity data on selected diseases for which a Eurostat Task Force Morbidity has been created. A close coordination with the OECD and the WHO is also of utmost importance in order to avoid to duplicate efforts and to make use of the experience in disease data build up in these organisations. 4. Organisation of the work of the Morbidity and Mortality Working Party The work of the MMWP will be assisted by a secretariat. The secretariat will be responsible for the coordination of meetings, preparing of background documents for meetings, overall coordination of the related projects under the Public Health Programme in close cooperation with the Commission Services. The Secretariat will be a central focus point for better coordination of the MMWP members and stakeholders (Commission, international organisations etc.). The Commission services and the MMWP shall agree to nominate among the participants a Working Party Leader and a Deputy. The Working Party Leader could co-chair the meetings with the Commission. The MMWP could create, if necessary, ad hoc Task Forces in order to carry out or guide development work in certain specific areas as indicated by the MMWP. Usually the Task Forces will deal with specific, large problems, which can not be solved by the MMWP. Taking account of specific needs in the field of rare diseases, it is suggested to create a Task Force on Rare Diseases.
4 The MMWP shall report on the selection of indicators on diseases to the Working Party Community Health Indicators which has been mandated to oversee the health indicator process. This Working Party will assume the role of Network of Working Party Leaders and report about the work of the Working Parties to the Network of Competent Authorities. 5. Tasks of the Morbidity and Mortality Working Party The tasks of the MMWP are: To communicate results to the Network of Competent Authorities with the aim of improving information flows, preparing decision making by the Member States and achieving the use of a common framework for information on diseases; To contribute with morbidity and mortality indicators to the development of a precisely-defined indicator list, used to prioritise and harmonise data collection, via the European Community Health Indicators (ECHI) projects 1 and 2; To develop health information and analysis and reporting systems, and to improve access to and transfer of data within the annual work plan and thereafter; To implement the annual work plan through networks of public health institutes, health monitoring authorities and the working party (MMWP) in the areas of morbidity and mortality; To contribute, in close coordination with the Task Force Morbidity of Eurostat, to collect comparable morbidity data at EU level, taking account of the very different situations normally encountered at national level. Special attention will be given to inventories and analysis source by source and to the harmonization and methodological description with a final objective: to compare what is really comparable; To contribute to the inventory and to the development of a comprehensive and comparable health measurement for health surveys in the EU and the Member States contributing to develop modules for surveys (HIS and HES). It is intended that models of varying intensity will be developed for the different circumstances in the Member States; To advise the Commission services in the implementation of disease or morbid conditions modules in the Commission Eurobarometer survey; The MMWP will contribute to the preparation of the annual work plans of the Public Health Programme It will assist the Commission in setting priorities in the field of information and knowledge on major and rare diseases, to target the information needs for monitoring initiatives on EU, national and regional level; It shall advise members and Commission Services for specific Public Health Programme projects which focus on morbidity and mortality namely the projects mentioned in the Annex, reviewing, in cooperation with the Commission services, the interim and final reports from projects; It shall advise members and Commission Services on the preparation of a European strategies in information on morbidity and mortality;
5 It will examine morbidity and mortality related issues in other Community policies and their impact (e.g. the Social Protection Committee); The MMWP shall meet at least twice per year. The meetings will be organised by the Commission Services in Luxembourg.
6 Annex List of the projects from the SANCO former programmes (Health Monitoring and Rare Diseases programmes) A. Indicators on major diseases Istituto Superiore di Sanità (Italy) Centre Hospitalier de Luxembourg (Luxembourg) Istituto Nazionale per lo studio e la cura dei tumori (Italy) University of Oslo (Norway) IARC / WHO (France) Fundació IMIM (Institut Municipal d'investigació Mèdica) (Spain) Cardiovascular Indicators Surveillance Set in Europe (EUROCISS 1) (phase 1) Establishment of Indicators Monitoring Diabetes Mellitus and its Morbidity (EUDIP) Health Indicators for Monitoring Cancer in Europe (EUROCHIP 1) (phase 1) Indicators for Monitoring Musculoskeletal Conditions Comprehensive Cancer Monitoring Programme in Europe (CAMON) Indicators for monitoring COPD (Chronical Obstructive Pulmonary Diseases) and asthma in the EU (IMCA) B. Improving health surveys Statistics Netherlands (The Netherlands) National Public Health Institute (KTL) (Finland) INSERM - Démographie et santé c/o Centre Régional de Lutte contre le Cancer de Montpellier (France) INSERM - Démographie et santé c/o Centre Régional de lutte contre le cancer de Montpellier (France) Health Surveys in the EU: HIS and HIS/HES evaluations and models (phase 1) Health Surveys in the EU: HIS and HIS/HES. Evaluations and Models (phase 2) Setting up a coherent set of Health Indicators for most of the Health Aspects (phase 1) Setting up a coherent set of Health Indicators for the European Union (phase 2)
7 C. Improving quality on Mortality data INSERM (Institut National de la Santé et de la Recherche Médicale) (France) Comparability and Quality Improvement in European Causes in Death Statistics D. Morbidity statistics and routine data Office for National Statistics (UK) Office for National Statistics (UK) Université Libre de Bruxelles - Ecole de Santé Publique (Belgium) Methodologies for Producing EU-wide Comparable Disease- Specific Morbidity Data (EUMIP 1) (phase 1) Methodologies for producing EU - Wide comparable disease - Specific morbidity data : enhancement of the electronic inventory of data sources (EUMIP 2) (phase 2) Situation in Europe regarding the Routine Collection of Medical Data and their use in Health Monitoring (EURO-MED-DATA) D. Indicators on health conditions Centre for Health Planning and Management - Keele University (UK) Assistance Publique / Hôpitaux de Paris - INSERM U 149 (France) Universidade de Lisboa - Instituto de Medecina Preventiva - Faculdade de Medicina (Portugal) Université Lyon 1 - Laboratoire d'analyse des systèmes de santé (France) Based on Live Data Child Health Indicators of Life and Development (Bold CHILD) Indicators for Monitoring and Evaluating Perinatal Health in Europe (PERISTAT) Reproductive health indicators in the EU (REPROSTAT) European Global Oral Health Indicators E. Rare diseases INSERM (Institut National de la Santé et de la Recherche Médicale) (France) Department of Internal Medicine - UMC (University Medical Center) ORPHANET 3 (Phase 3) TEAM 2 Ongoing transfer of expertise on prevention, diagnosis and treatment of common complications in adults with rare metabolic diseases (Phase 2)
8 (The Netherlands) Fundació Privada per a la Recerca Biomèdica (Spain) Alzheimer Europe (Luxembourg) European Federation for Neurofibromatosis (Belgium) EURORDIS (European Organisation for Rare Disorders) (France) Centro Nazionale Malatie Rare - Istituto Superiore di Sanità (Italy) University of Ulster (United Kingdom) Medizinische Hochschule Hannover (Germany) PRINTO (Paediatric Rheumatology International Trials Organisation) (Italy) University of Graz (Austria) EURORDIS (European Organisation for Rare Disorders) (France) Istituto di Ricerche Farmacolociche Mario Negri (Italy) Sense International (United Kingdom) INSERM (Institut National de la Santé et de la Recherche Médicale) () (France) SPK (Schlosspark-Klinik KG) (Germany) ENERCA - European Network for Rare Congenital Anaemias Rare Forms of Dementia Project to establish European neurofibromatoses lay group network. Health promotion improving health information and knowledge for neurofibromatoses (NF) in Europe Pan-European network for patients information on rare diseases and orphan drugs (PARD 3) NEPHIRD 2 - a European network for epidemiological and public health data collection on rare diseases (phase 2) EUROCAT 2 : Surveillance of congenital anomalies in Europe (Phase 2) European Network on the epidemiology, pathophysiolgy and treatment of severe chronic neutropenia A European Information Network on Paediatric Rheumatic diseases Rare pulmonary diseases - set up of diagnostic criteria and reference/training center New communication technologies (web site) to the service of the rare disorders network and sharing of good practices in different help services to patients, already existing in Europe (PARD 2) A european educational programme on rare diseases CAUSE - Charge association and Usher Syndrome in Europe ORPHANET 2 (Phase 2) EUROMUSCLENET- Muscle diseases - Prototype of rare and disabling disorders: creation of a European Information Network
9 IPG (Institut de Pathologie et de Génétique) (Belgium) INSERM (Institut National de la Santé et de la Recherche Médicale) () (France) University of Tampere (Finland) Department of Internal Medicine - UMC (University Medical Center) (The Netherlands) Genetic Interest Group (United Kingdom) EURORDIS (European Organisation for Rare Disorders) (France) University of Ulster (United Kingdom) Centro Nazionale Malatie Rare - Istituto Superiore di Sanità (Italy) EDDNAL - European Directory of DNA Laboratories ORPHANET 1: A european database on rare diseases and orphan drugs (PHASE 1) Information network for immunodeficiencies TEAM 1 Transfer of expertise on rare metabolic diseases in adults (phase 1) Creating a European Alliance of Patient and parent groups for genetic services and innovation in medicine (EAGS) Orphan medicinal products to the service of patients affected by rare diseases (PARD 1) EUROCAT1: Surveillance of congenital anomalies in Europe (Phase 1) NEPHIRD 1- a European network for epidemiological and public health data collection on rare diseases (phase 1
European Haemophilia Consortium
European Haemophilia Consortium Response to the European Commission Public Consultation on rare diseases: Europe s challenges The European Haemophilia Consortium 1 (EHC) is a European patient group representing
More informationNational Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health
National Plans for Rare Diseases The French plan 2005-2008 2008 Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health Political Context Public Health Law of 9 August 2004 100
More informationStrategic thinking across the EU through the eyes of SHIPSAN
PRE-CONFERENCE Workshop on the Implementation of innovations in public health policy and practice under the auspices of EUPHA Conference Strategic thinking across the EU through the eyes of SHIPSAN Stockholm,
More informationDocument: Report on the work of the High Level Group in 2006
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL HIGH LEVEL GROUP ON HEALTH SERVICES AND MEDICAL CARE Document: Report on the work of the High Level Group in 2006 Date: 10/10/2006 To:
More informationEUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)
EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO
More informationEUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES
EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference
More informationOverview on diabetes policy frameworks in the European Union and in other European countries
Overview on policy frameworks in the European Union and in other European countries Countries plan Guidelines Belgium Guidelines for good medical practice type 2 The Belgian is limited to newly diagnosed
More informationEU HEALTHY GATEWAYS Joint Action Preparedness and action at points of entry (ports, airports, ground crossings)
EU HEALTHY GATEWAYS Joint Action 04-2017 Preparedness and action at points of entry (ports, airports, ground crossings) Barbara Mouchtouri, MSc, PhD Leader Work Package 7 of EU HEALTHY GATEWAYS Joint Action
More informationThe Role and Responsibilities of the Medical Physicist in MRI in Europe
Stelios Christofides EFOMP Immediate Past President cstelios@cytanet.com.cy OUTLINE The Legal Framework The Problem The MRI Alliance Status of Play Reference Websites The EFOMP Activities 2 The Legal Framework
More informationWork Plan 2008: priorities Cinthia Menel Lemos (PHEA)
Work Plan 2008: priorities Cinthia Menel Lemos (PHEA) 1 Health Plan 2008 Issues of strategic importance Improve the health of European citizens, as measured by indicators (Health Life Years) Reduce health
More information2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois
2nd European Reference Networks Conference 8-9 October Lisbon, Portugal A report by: G Porto & F Courtois (invited by EURORDIS) summary I INTRODUCTION What does a ERN mean? What will we (patients) gain
More informationEuropean Reference Networks (ERN) Guide for patient advocates
European Reference Networks (ERN) Guide for patient advocates 1. European Reference Networks (page 1-3) a. What is an ERN? b. Who is a member of an ERN? c. Affiliated/ collaborative centres d. The IT platform
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 6.8.2013 COM(2013) 571 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on implementation of the Regulation (EC) No 453/2008 of the European Parliament
More informationImplementation of the System of Health Accounts in OECD countries
Implementation of the System of Health Accounts in OECD countries David Morgan OECD Health Division 2 nd December 2005 1 Overview of presentation Main purposes of SHA work at OECD Why has A System of Health
More informationDeveloping a European Registry for Rare Anaemias
Developing a European Registry for Rare Anaemias Michael Angastiniotis Thalassaemia International Federation 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS 1 st Dutch-Belgian meeting for patients and health
More informationEFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
EFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE EFLM connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European Specialists
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 8.7.2016 COM(2016) 449 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on implementation of Regulation (EC) No 453/2008 of the European Parliament
More informationThe Voice of Foreign Companies. Healthcare Policy Agenda. Bringing the Benefits of Innovative Practices to Denmark
The Voice of Foreign Companies Healthcare Policy Agenda Bringing the Benefits of Innovative Practices to Denmark November 24, 2008 Background The Healthcare Ambition We are convinced that Denmark has the
More informationAnnual Work Programme 2018
Annual Work Programme 2018 Infoday 30 January 2018 Irène ATHANASSOUDIS DG SANTE C1 The Health Programme Regulation EU N 282/2014 of 11 March 2014 Promoting health Encouraging innovation in health Complement,
More informationREFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT
REFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT A. INTRODUCTION REFLECTION PROCESS In conclusions adopted in March 2010, the Council called upon the Commission and Member States to launch a reflection
More informationEUROCORES Programme European Collaborative Research. ECT Pan-European Clinical Trials.
EUROCORES Programme European Collaborative Research ECT Pan-European Clinical Trials www.esf.org EUROCORES Programme European Collaborative Research The Scientific Goal of the ECT (Pan-European Clinical
More informationTable Of Content. Outputs... 6
Table Of Content The EU Contribution to the World Mental Health ( Surveys Initiative... 2 Summary... 3 Coordinator, Leader contact and partners... 4 University of Ulster - UU... 4 Ecole des Hautes Etudes
More informationUnmet health care needs statistics
Unmet health care needs statistics Statistics Explained Data extracted in January 2018. Most recent data: Further Eurostat information, Main tables and Database. Planned article update: March 2019. An
More informationESF Member Organisation Fora on. European Alliance for Research Career Development
ESF Member Organisation Fora on European Alliance for Research Career Development Laura Marin, Member and Policy relations, ESF ENRC meeting, Brussels, 30 October 2012 Topics 1. Background on ESF MO Fora
More information116 Help Lines for Rare Diseases
116 Help Lines for Rare Diseases François Houÿez Director of Health Policy Council of National Alliances, 29 October 2012, Paris Credits ENRDHL is one of the outcomes of the RAPSODY project supported by
More informationCouncil of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union
Council of the European Union Brussels, 8 September 2014 (OR. en) 12943/14 SAN 336 RECH 359 MI 637 COVER NOTE From: date of receipt: 5 September 2014 To: No. Cion doc.: Subject: Secretary-General of the
More informationSkillsnet workshop. "Job vacancy Statistics"
EUROPEAN COMMISSION EUROSTAT Directorate F: Social Statistics and Information Society Unit F-2: Labour market statistics Skillsnet workshop Bucarest, 21-22 June 2007 "Job vacancy Statistics" Eurostat contact:
More informationCapacity Building in the field of youth
Capacity Building in the field of youth What are the aims of a Capacity-building project? Youth Capacity-building projects aim to: foster cooperation and exchanges in the field of youth between Programme
More informationERN Assessment Manual for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0
More informationEU Health Programmes
Evaluation of the Health Programme 2008-2013 and Future actions under the new Health Programme 2014-2020 Michael Hübel Health Programme Management and Diseases DG Health and Consumers European Commission
More informationErasmus for Young Entrepreneurs Users Guide
Erasmus for Young Entrepreneurs Users Guide An initiative of the European Union Contents PAGE 1.0 Introduction... 5 2.0 Objectives... 6 3.0 Structure... 7 3.1 Basic elements...7 3.2 Four phases...8 4.0
More informationStudy on Organisational Changes, Skills and the Role of Leadership required by egovernment (Working title)
Study on Organisational Changes, Skills and the Role of Leadership required by egovernment (Working title) Version 4 21/02/2005 Christine Leitner OUTLINE Background The present working plan of the EPAN
More informationInvolvement of ESF and EMRC in Clinical Trials Wellcome Trust, London, 16 March 2010 by Dr. Maria Manuela Nogueira ESF Science Officer.
Involvement of ESF and EMRC in Clinical Trials Wellcome Trust, London, 16 March 2010 by Dr. Maria Manuela Nogueira ESF Science Officer www.esf.org 1 ESF Member Organisations ESF is an independent nongovernmental
More informationErasmus Student Work Placement Guide
Erasmus Student Work Placement Guide Introduction This Guide is intended to provide general information for students who are considering an Erasmus work placement. It must be stressed that the advice is
More informationWORLD HEALTH ORGANIZATION
WORLD HEALTH ORGANIZATION FIFTY-THIRD WORLD HEALTH ASSEMBLY A53/14 Provisional agenda item 12.11 22 March 2000 Global strategy for the prevention and control of noncommunicable diseases Report by the Director-General
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationFirst quarter of 2014 Euro area job vacancy rate up to 1.7% EU28 up to 1.6%
94/2014-17 June 2014 First quarter of 2014 Euro area job vacancy rate up to 1.7% EU28 up to 1.6% Today, Eurostat publishes for the first time a News Release with quarterly data on the job vacancy rate.
More informationHealth Professionals in EULAR December 2016
Health Professionals in EULAR December 2016 Contents The origins and today Structure and organization within EULAR Membership 2016 Strategic objectives 2017 Strategic work Scientific Sub Committee Educational
More informationTable Of Content. Outputs... 9
Table Of Content European Musculoskeletal Conditions Surveillance and Information Network... 3 Summary... 4 Coordinator, Leader contact and partners... 5 Dr I Cantacuzino Clinical Hospital... 5 University
More informationECHA Helpdesk Support to National Helpdesks
ECHA Helpdesk Support to National Helpdesks 48 th Biocides CA meeting 19-21 September 2012 Brussels Dr. Henna Piha ECHA Helpdesk Unit A1 ECHA Helpdesk - Support to National Helpdesks What ECHA offers to
More informationMeasuring R&D in the Nonprofit Sector: The European Experience
Measuring R&D in the Nonprofit Sector: The European Experience Aldo Geuna (University of Torino - BRICK, Collegio Carlo Alberto, Torino) Measuring Research and Development Expenditures in the U.S. Nonprofit
More informationEU RESEARCH FUNDING Associated countries FUNDING 70% universities and research organisations. to SMEs throughout FP7
10 KEY FACTS 1 BUDGET TOTAL 55 billion 82% 18% 4 specific programmes* Cooperation - 28.7bn Ideas - 7.7bn People - 4.8bn Capacities - 3.8bn Euratom, JRC direct actions, ITER, Risk Sharing Finance Facility
More informationHEALTH WORKFORCE MIGRATION:
HEALTH WORKFORCE MIGRATION: RESULTS FROM 2013-14 PILOT DATA COLLECTION AND PROPOSAL TO ADD MODULE IN THE JOINT QUESTIONNAIRE OECD Health Data National Correspondents 23 October 2014, Paris OECD pilot data
More informationLessons from the EMA Patient Registries Initiative
Lessons from the EMA Patient Registries Initiative STAMP Commission Expert Group 8 th June 2018 Presented by Peter Arlett, with contributions from Patricia McGettigan and Jane Moseley Head of Pharmacovigilance
More informationBELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)
BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD) Brussels, 19 October 2010 Summary Report Background and Objectives of the conference The Conference on Rheumatic and Musculoskeletal
More informationStrategic Enhancement of Laboratory and Epidemiology Surveillance
Strategic Enhancement of Laboratory and Epidemiology Surveillance WHO/CSR Lyon, France Emerging/re-emerging Infectious Diseases 1996-2001 E P I D E M I C A L E R T & R E S P O N S E I N T E R N A T I O
More informationTable Of Content. Single Hub and Access point for paediatric Rheumatology in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content Single Hub and Access point for paediatric Rheumatology in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Univerzita Karlova v Praze - CUNI... 5 Eberhard Karls
More informationEHEMU Technical report 2010_4.6 June 2010 The Minimum European Health Module
EHEMU Technical report 2010_4.6 June 2010 The Minimum European Health Module Background documents The EHEMU/EHLEIS team comprises: Jean-Marie Robine, Health and Demography, University of Montpellier, France,
More informationHarmonized European standards for construction in Egypt
Harmonized European standards for construction in Egypt JRC Support for the Eurocodes Adamantia Athanasopoulou Post-doctorate Research Fellow Joint Research Centre, European Commission Organised with the
More informationEuropean Musculoskeletal Conditions Surveillance and Information Network(EUMUSC.NET) Summary. Project N under EU Health Programme
Project N 20081301 under EU Health Programme 2008-2013 European Musculoskeletal Conditions Surveillance and Information Network(EUMUSC.NET) Summary 1. General objectives The project intends to raise and
More informationSOUTH AFRICA EUREKA INFORMATION SESSION 13 JUNE 2013 How to Get involved in EUROSTARS
EUREKA SOUTH AFRICA EUREKA INFORMATION SESSION 13 JUNE 2013 How to Get involved in EUROSTARS Michel Andrieu Adviser to the Head of the EUREKA Secretariat Doing business through technology The Eurostars
More informationBuilding the Europe of Knowledge
Building the Europe of Knowledge Investigación Europea en Cuidados de Salud Kevin McCarthy European Commission Public Health Research A science driven approach - Biotechnology, Agriculture... Biomedicine
More informationERA-Can+ twinning programme Call text
ERA-Can+ twinning programme Call text About ERA-Can+ ERA-Can+ promotes cooperation between the European Union (EU) and Canada across the science, technology and innovation chain to support and encourage
More informationTRENDS IN HEALTH WORKFORCE IN EUROPE. Gaétan Lafortune, OECD Health Division Conference, Brussels, 17 November 2017
TRENDS IN HEALTH WORKFORCE IN EUROPE Gaétan Lafortune, OECD Health Division Conference, Brussels, 17 November 2017 Health and social workers account for a growing share of total employment in nearly all
More information1 of Webmaster WHY INSPIRE? WHAT'S NEW OPEN LETTER KEEP INFORMED / REGISTER REQUEST FOR EXPERTS
1 of 5 HOME WHY INSPIRE? WHAT'S NEW OPEN LETTER KEEP INFORMED / REGISTER REQUEST FOR EXPERTS Registered SDIC/LMOs SDIC/LMO LOGIN and REGISTRATION CONSULTATIONS INSPIRE DIRECTIVE INSPIRE WORKPROGRAMME INSPIRE
More informationMorbidity statistics in the EU
Morbidity statistics in the EU Bridge Health WP8, final meeting, Rome 14 Sep 2017 Platform for population-based registries Marleen De Smedt, Adviser to the DG, Eurostat European Commission 1 Eurostat Eurostat
More informationEGOHID II FINAL IMPLEMENTATION REPORT. January 2009
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL European Global Oral Health Indicator Development Project II University Lyon EGOHID II FINAL IMPLEMENTATION REPORT January 2009 TABLE
More informationPLATFORM FOR POPULATION-BASED REGISTRIES Manual of operations WP8 - task 1 report
PLATFORM FOR POPULATION-BASED REGISTRIES Manual of operations WP8 - task 1 report 30.10.2017 Project Leader: Simona Giampaoli Istituto Superiore di Sanità Viale Regina Elena 299 00161 Rome, Italy Tel +390649904231
More informationErasmus+: Knowledge Alliances and Sector Skills Alliances. Infoday. 23 November María-Luisa García Mínguez, Renata Russell (EACEA) 1
Erasmus+: Knowledge Alliances and Sector Skills Alliances Infoday 23 November 2015 María-Luisa García Mínguez, Renata Russell (EACEA) 1 How to submit a proposal María Luisa G. Mínguez, Renata Russell Education,
More informationThe Third EU Health Programme
The Third EU Health Programme With a focus on joint actions Stockholm, 22 August 2014 Dirk MEUSEL Scientific Project Officer European Commission Health and Food Exectutive Agency (Chafea) What's new? EAHC
More informationMeeting report series. Report of the 2nd Funders Constituent Committee Meeting
Meeting report series Report of the 2nd Funders Constituent Committee Meeting Teleconference July 12, 2017 Participants Dr Daria Julkowska, E-RARE-3 Consortium, France (Chair) Prof Hugh Dawkins, Western
More informationPresentation of a protocol of severe maternal morbidity surveillance using hospital discharge data in Europe : a feasibility study
Chantry Anne Bouvier-Colle Marie-Hélène Inserm U 953 Presentation of a protocol of severe maternal morbidity surveillance using hospital discharge data in Europe : a feasibility study EURO-Peristat II
More informationEUREKA and Eurostars: Instruments for international R&D cooperation
DLR-PT.de Chart 1 EUREKA / Eurostars Dr. Paul Racec 18 th May 2017 EUREKA and Eurostars: Instruments for international R&D cooperation DLR-PT - National Contact Point EUREKA/Eurostars Dr. Paul Racec DLR-PT.de
More informationAlpbach Technology Forum, The Efficiency of RTI Investments, 26 August 2011 EU RESEARCH : VALUE FOR MONEY?
Alpbach Technology Forum, The Efficiency of RTI Investments, 26 August 2011 EU RESEARCH : VALUE FOR MONEY? Wolfgang Burtscher DG Research and Innovation European Commission Structure PART I. About the
More informationERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation
ERC Grant Schemes Horizon 2020 European Union funding for Research & Innovation The ERC funding strategy The European Research Council (ERC) is the first pan- European funding body designed to support
More informationLabco. Consultation on healthcare mobility
Labco Consultation on healthcare mobility 2007 Labco SAS, 34 boulevard Haussmann, 75009 Paris, France Labco Diagnostics, 480 avenue Louise, 1050 Brussels, Belgium Labco Liguria, Via Roma 166, 18038 San
More informationPUBLIC. 6393/18 NM/fh/jk DGC 1C LIMITE EN. Council of the European Union Brussels, 1 March 2018 (OR. en) 6393/18 LIMITE
Conseil UE Council of the European Union Brussels, 1 March 2018 (OR. en) 6393/18 LEGISLATIVE ACTS AND OTHER INSTRUMENTS Subject: LIMITE PUBLIC CORLX 98 CFSP/PESC 169 CSDP/PSDC 83 FIN 145 COUNCIL DECISION
More informationoffered by the INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC
Services and activities offered by the INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC The Institut national de santé publique du Québec (INSPQ) was created in 1998 following the adoption of its act of incorporation
More informationERASMUS+ Study Exchanges and Traineeships. Handbook for School/Departmental Exchange Co-ordinators
ERASMUS+ Study Exchanges and Traineeships Handbook for School/Departmental Exchange Co-ordinators March 2017 Version 5 Contents 1. Introduction 2. ERASMUS+ and the British Council Funding Cycle Operational
More informationAPPENDIX B: Organizational Profiles of International Digital Government Research Sponsors. New York, with offices in Geneva, Vienna, and Nairobi
United Nations - Division for Public Administration and Development Management (UN-DPADM) New York, with offices in Geneva, Vienna, and Nairobi Maintaining international peace and security, developing
More informationIndicators for Monitoring COPD and asthma in the EU NEW WORK PLAN PROPOSAL
Indicators for Monitoring COPD and asthma in the EU NEW WORK PLAN PROPOSAL October November 2003 INDE 1. BACKGROUND.. 2 2. AIMS 6 2.1 General.. 6 2.2 Specific.. 6 3. ORGANIZATION AND MANAGEMENT 7 3.1 Steering
More informationNetwork development for partnerships & cooperation programs fostering service innovation
Network development for partnerships & cooperation programs fostering service innovation Anca Daniela Ionita University POLITEHNICA of Bucharest Strategic Program for Promoting Innovation in Services by
More informationBUILDING A SUPPORTIVE SHELTER FOR VOLUNTEERING IN EUROPE
BUILDING A SUPPORTIVE SHELTER FOR VOLUNTEERING IN EUROPE LESTER M. SALAMON Johns Hopkins University Rome, Italy 19 April 2012 SECURING VOLUNTEERING S FUTURE BARRIERS I M P A C T S ON BENEFI- CIARIES ON
More informationPERFORMANCE OF THE BELGIUM HEALTH SYSTEM IN INTERNATIONAL COMPARISON
PERFORMANCE OF THE BELGIUM HEALTH SYSTEM IN INTERNATIONAL COMPARISON Academic session: Looking back with an eye on the future 13 January 2017 Mark Pearson - Deputy Director Employment, Labour and Social
More information3rd Health Programme
3rd Health Programme 2014-2020 Joint Action to strengthen preparedness in the EU against serious cross-border threats to health and support the implementation of the International Health Regulations Luxembourg,
More informationThe European Entrepreneur Exchange Programme. Users' Guide. European Commission Enterprise and Industry
The European Entrepreneur Exchange Programme Users' Guide European Commission Enterprise and Industry Contents 1.0 Introduction...5 2.0 Objectives...6 3.0 Structure...7 3.1 Basic elements...7 3.2 Four
More informationOIE Regional Platform on Animal Welfare for Europe
OIE Regional Platform on Animal Welfare for Europe Annual Meeting of the OIE Regional and Sub Regional Representations Paris, 22 25 October 2013 Dr. Stanislav Ralchev OIE SRR in Brussels Table of content
More informationElectronic Health Records for research and Hospital management. The "Assistance Publique - Hôpitaux de Paris" initiative
Electronic Health Records for research and Hospital management The "Assistance Publique - Hôpitaux de Paris" initiative Pr Philippe Lechat Clinical Research Department, St Louis Hospital, AP-HP, Paris
More informationEU HEALTH POLICY PLATFORM CALL TO ACTION ON ANTIMICROBIAL RESISTANCE (AMR)
EU HEALTH POLICY PLATFORM CALL TO ACTION ON ANTIMICROBIAL RESISTANCE (AMR) February 2018 The signatories welcome the new EU One Health Action Plan on AMR as an acknowledgement of the gravity of the AMR
More informationHealth First Europe calls on the EU Institutions to Champion Patient Safety
Health First Europe calls on the EU Institutions to Champion Patient Safety Recommendations on Patient Safety Since 2004, Health First Europe has been actively involved in the issue of patient safety at
More informationCOMMISSION STAFF WORKING DOCUMENT. Assessment of stakeholders' experience with the European Professional Card and the Alert Mechanism procedures
EUROPEAN COMMISSION Brussels, 9.4.2018 SWD(2018) 90 final COMMISSION STAFF WORKING DOCUMENT Assessment of stakeholders' experience with the European Professional Card and the Alert Mechanism procedures
More informationEU PRIZE FOR WOMEN INNOVATORS Contest Rules
EU PRIZE FOR WOMEN INNOVATORS 2014 Contest Rules DEFINITIONS: Prizes under the Seventh Framework Programme (FP7) are awarded following a contest. The European Prize for Women Innovators 2013 is published
More informationDescriptive Note. Coordinator: European Centre for Social Welfare Policy and Research Vienna
Coordinator: European Centre for Social Welfare Policy and Research Vienna European Centre for Social Welfare Policy and Research (AT) Ecole d'études sociales et pédagogiques (CH) University of Southern
More informationThe EUREKA Initiative An Opportunity for Industrial Technology Cooperation between Europe and Japan
EUREKA The EUREKA Initiative An Opportunity for Industrial Technology Cooperation between Europe and Japan Brussels, 12 March 2014 Susanne Madders Senior International Cooperation Advisor EUREKA Secretariat,
More informationTO REACH: organizing health service and system research in Europe
Health Systems Innovation and Transformation: Accelerating Cross Border Learning TO REACH: organizing health service and system research in Europe Stefano Vella MD Istituto Superiore di Sanità (the Italian
More informationFACULTY OF PUBLIC HEALTH DEPARTMENT OF PUBLIC HEALTH SCIENCIES
SYNOPSIS Page 1 of 7 FACULTY OF PUBLIC HEALTH DEPARTMENT OF PUBLIC HEALTH SCIENCIES EXAMINATION SYNOPSIS IN SOCIAL MEDICINE 2015/2016 Specialty Medicine, Second year students (January 2016 examination
More informationERASMUS+ INTERNSHIP MOBILITY?
ERASMUS+ INTERNSHIP MOBILITY? Tuesday, March 21 5.20 pm Nador 13, 307/A WHAT IS ERASMUS+ Internship Mobility? 2 12 months many organizations in Programme Countries non-eligible receiving institutions:
More informationPolicies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe
Policies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe A. Eleftheriou, Ph.D Thalassaemia International Federation 4th European
More informationEDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa.
EDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa. Info Day, Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing 8 July 2016, Brussels
More informationPatient Registries Initiative Background, Achievements, Next steps
Patient Registries Initiative Background, Achievements, Next steps 21 November 2017 ENCePP Plenary meeting Presented by Xavier Kurz, Surveillance & Epidemiology Service, European Medicines Agency An agency
More informationThe ERC funding strategy
The European Research Council ERC Grant Schemes FUNDING TOP RESEARCHERS http://erc.europa.eu The ERC funding strategy The European Research Council (ERC) is the first pan- European funding body designed
More informationSwiss interim solution for Erasmus+ SEMP: Swiss-European mobility programme
Swiss interim solution for Erasmus+ SEMP: Swiss-European mobility programme 29th of June 2016 Catherine Carron Project coordinator Erasmus Swiss National Agency / ch Foundation Content v Short presentation
More informationConsultation: Transformation Health and Care in the Digital Single
Synopsis Report Consultation: Transformation Health and Care in the Digital Single Market Digital Single Market Prepared by the European Commission DG Communications Networks, Content & Technology and
More informationA European workforce for call centre services. Construction industry recruits abroad
4 A European workforce for call centre services An information technology company in Ireland decided to use the EURES services to help recruit staff from the European labour market for its call centre
More informationCommission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo
Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal
More informationArchimedes Distinctions for High-level Research Work
European Commission Community Research Information Package Information Brochure Call Specific Archimedes Distinctions for High-level Research Work Edition September 2001 Call identifier: IHP-ARP-01-1 http://www.cordis.lu/improving
More informationCAP GEMINI ERNST & YOUNG S OVERALL REPORT OCT 2001 OCT 2002 ONLINE AVAILABILITYOF PUBLIC SERVICES: HOW DOES EUROPE PROGRESS?
CAP GEMINI ERNST & YOUNG S OVERALL REPORT OCT 2001 OCT 2002 ONLINE AVAILABILITYOF PUBLIC SERVICES: HOW DOES EUROPE PROGRESS? WEB BASED SURVEY ON ELECTRONIC PUBLIC SERVICES Prepared by: Cap Gemini Ernst
More information1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.
Council of the European Union Brussels, 14 November 2014 (OR. en) 15441/14 SAN 429 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social
More informationKnowledge for welfare and health 1. National Research and Development Centre for Welfare and Health
Knowledge for welfare and health 1 Introduction Vappu Taipale Knowledge for welfare and health 2 Contents STAKES in brief FP5 Key Action 6 and its External Advisory Group EAG s recommendations Expectations
More informationEIB-Universities Research Action Fifth Annual Meeting February 2 nd Maria Luisa Ferreira EIB Institute
EIB-Universities Research Action Fifth Annual Meeting February 2 nd 2012 Maria Luisa Ferreira EIB Institute Overview of the Meeting EIB Institute Snapshot of Programme Activities Implementation Procedures
More information